Bausch Health Companies Inc.
BHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$72,000 | -$611,000 | -$212,000 | -$937,000 |
| Dep. & Amort. | $1,267,000 | $1,264,000 | $1,394,000 | $1,552,000 |
| Deferred Tax | $66,000 | $51,000 | -$176,000 | -$225,000 |
| Stock-Based Comp. | $150,000 | $132,000 | $126,000 | $128,000 |
| Change in WC | $7,000 | -$582,000 | -$396,000 | -$128,000 |
| Other Non-Cash | $179,000 | $778,000 | -$1,464,000 | $1,036,000 |
| Operating Cash Flow | $1,597,000 | $1,032,000 | -$728,000 | $1,426,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$337,000 | -$215,000 | -$218,000 | -$269,000 |
| Net Acquisitions | $0 | -$1,890,000 | -$45,000 | $0 |
| Inv. Purchases | -$12,000 | -$27,000 | -$17,000 | -$19,000 |
| Inv. Sales/Matur. | $14,000 | $26,000 | $22,000 | $15,000 |
| Other Inv. Act. | -$119,000 | -$39,000 | -$45,000 | $682,000 |
| Investing Cash Flow | -$454,000 | -$2,145,000 | -$303,000 | $409,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$799,000 | $1,581,000 | -$1,010,000 | -$1,340,000 |
| Stock Issued | $0 | $0 | $675,000 | $0 |
| Stock Repurch. | -$26,000 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$43,000 | -$106,000 | -$139,000 | -$173,000 |
| Financing Cash Flow | -$868,000 | $1,475,000 | -$474,000 | -$1,513,000 |
| Forex Effect | -$36,000 | $9,000 | -$23,000 | -$19,000 |
| Net Chg. in Cash | $239,000 | $371,000 | -$1,528,000 | $303,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $962,000 | $591,000 | $2,119,000 | $1,816,000 |
| End Cash | $1,201,000 | $962,000 | $591,000 | $2,119,000 |
| Free Cash Flow | $1,260,000 | $760,000 | -$996,000 | $1,143,000 |